Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH

Open source

DOI
10.1016/s1470-2045(21)00470-8
Published
2022 Jan
Container
The Lancet. Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-21-00470-8,
  title = {Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.},
  author = {Mauz-Körholz C and Landman-Parker J and Balwierz W and Ammann RA and Anderson RA and Attarbaschi A and Bartelt JM and Beishuizen A and Boudjemaa S and Cepelova M and Claviez A and Daw S and Dieckmann K and Fernández-Teijeiro A and Fosså A and Gattenlöhner S and Georgi T and Hjalgrim LL and Hraskova A and Karlén J and Kluge R and Kurch L and Leblanc T and Mann G and Montravers F and Pears J and Pelz T and Rajić V and Ramsay AD and Stoevesandt D and Uyttebroeck A and Vordermark D and Körholz D and Hasenclever D and Wallace WH},
  year = {2022},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(21)00470-8},
  url = {https://doi.org/10.1016/s1470-2045(21)00470-8}
}

RIS

TY  - JOUR
TI  - Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
AU  - Mauz-Körholz C
AU  - Landman-Parker J
AU  - Balwierz W
AU  - Ammann RA
AU  - Anderson RA
AU  - Attarbaschi A
AU  - Bartelt JM
AU  - Beishuizen A
AU  - Boudjemaa S
AU  - Cepelova M
AU  - Claviez A
AU  - Daw S
AU  - Dieckmann K
AU  - Fernández-Teijeiro A
AU  - Fosså A
AU  - Gattenlöhner S
AU  - Georgi T
AU  - Hjalgrim LL
AU  - Hraskova A
AU  - Karlén J
AU  - Kluge R
AU  - Kurch L
AU  - Leblanc T
AU  - Mann G
AU  - Montravers F
AU  - Pears J
AU  - Pelz T
AU  - Rajić V
AU  - Ramsay AD
AU  - Stoevesandt D
AU  - Uyttebroeck A
AU  - Vordermark D
AU  - Körholz D
AU  - Hasenclever D
AU  - Wallace WH
PY  - 2022
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(21)00470-8
UR  - https://doi.org/10.1016/s1470-2045(21)00470-8
ER  -

APA

C, M., J, L., W, B., RA, A., RA, A., A, A., JM, B., A, B., S, B., M, C., A, C., S, D., K, D., A, F., A, F., S, G., T, G., LL, H., A, H., J, K., R, K., L, K., T, L., G, M., F, M., J, P., T, P., V, R., AD, R., D, S., A, U., D, V., D, K., D, H., & WH, W. (2022). Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(21)00470-8

Source records